The Alzheimer's Association is inviting Permian Basin residents to join the fight to end Alzheimer's by participating in the Alzheimer's Association Walk to End Alzheimer's Oct. 26 at the Scharbaurer ...
The GLP-1 RA semaglutide was associated with a 40%-70% reduced risk for first-time diagnosis of AD in patients with type 2 diabetes, real-world data show.